High Prevalence of DMD and R&D of New Therapies for DMD Treatment to Augment Growth of Duchenne Muscular Dystrophy (DMD) Treatment Market
Duchenne Muscular Dystrophy (DMD) is a rare hereditary disease that affects the muscles and the connective tissue of the body. This condition is usually identified through skin tests and in more severe cases, it can be detected through MRI. The symptoms include drooping eyelids, decreased muscle bulk, weak pulse, and slow heart rate. The cause of this disease is not yet known but it is believed to be due to genetic differences, abnormalities in the nervous system, and infection. Market Dynamics High prevalence of DMD is expected to propel growth of the Duchenne muscular dystrophy (DMD) treatment market. For instance, according to the study, ‘Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis’ published in June 2020, in BMC, the pooled global prevalence of DMD was 7.1 cases per 100,000 males and 2.8 cases per 100,000 in the general population, while the pooled global birth prevalence of DMD was 19.8 per 100,000 live male b...